pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Iambic Therapeutics Inc · news · pharmadog
← back to Iambic Therapeutics Inc
News mentioning Iambic Therapeutics Inc
18
stories
21d
Flagship blends three biotech startups to form Etcelera
biopharma dive
28d
Biotech notches 31 IPOs already this year, with 4 more joining queue
biospace
Oct 16, 26
Iambic CEO on taking an AI drug company public
biopharma dive
Oct 16, 26
City’s IPO soars to $200M, with proceeds supporting thromboembolic disease pipeline
biospace
Oct 15, 26
Updated: Iambic rises after $150M IPO for AI-driven cancer pipeline
endpoints
Oct 15, 26
Iambic goes public with $150M IPO to accelerate clinical development of oncology pipeline
fiercebiotech
Oct 15, 26
Iambic, an AI drug discovery specialist, banks $150M in an IPO
biopharma dive
Oct 12, 26
Parkinson’s cell therapy developer files to go public
biopharma dive
Oct 9, 26
TRexBio, Retension raise $161.7M in IPOs; City, Iambic set proposed offering terms
biospace
Oct 9, 26
Lilly-backed TRex rakes in $117M IPO, while hypertension biotech Retension reveals $45M listing
fiercebiotech
Oct 8, 26
AI biotech Iambic aims for $135M IPO to push cancer drugs through clinic
fiercebiotech
Sep 25, 26
ADARx raises $446M in biotech’s third largest IPO of 2026, City files to go public
biospace
Sep 25, 26
RNAi drug specialist ADARx raises $446M IPO
biopharma dive
Sep 22, 26
Nvidia-backed AI biotech Iambic Therapeutics files for IPO
endpoints
Sep 22, 26
2026 IPO blitz continues with 4 new biotech filings
biospace
Sep 22, 26
Iambic maintains momentum from string of Big Pharma partnerships by aiming for IPO
fiercebiotech
Sep 21, 26
Iambic signs AbbVie deal, releases next generation of Enchant model
endpoints
Sep 16, 26
Novo looks to Anthropic’s AI models to ‘supercharge’ drug development
biopharma dive